Assembly and Functionalization of DNA−Polymer Microcapsules

We report the synthesis and characterization of DNA-grafted poly(N-isopropylacrylamide) (PNIPAM) micelles, their assembly into multilayered thin films, and the subsequent generation and poly(ethylene glycol) (PEG) functionalization of DNA−PNIPAM microcapsules. Multilayer films were assembled by sequ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS nano 2009-01, Vol.3 (1), p.234-240
Hauptverfasser: Cavalieri, Francesca, Postma, Almar, Lee, Lillian, Caruso, Frank
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We report the synthesis and characterization of DNA-grafted poly(N-isopropylacrylamide) (PNIPAM) micelles, their assembly into multilayered thin films, and the subsequent generation and poly(ethylene glycol) (PEG) functionalization of DNA−PNIPAM microcapsules. Multilayer films were assembled by sequentially depositing DNA-grafted PNIPAM micelles containing the cDNA sequences polyA30 or polyT30 (i.e., PNIPAM-A30 or PNIPAM-T30). DNA−polymer microcapsules were obtained by the alternate deposition of PNIPAM-A30 and PNIPAM-T30 onto silica particles, followed by removal of the template core. Upon removal of the silica core particle, shrinkage of between 30 and 50% was observed for the microcapsules. The presence of PNIPAM within the DNA−polymer hybrid film reduces the permeability of the microcapsules to macrosolutes (e.g., dextran) compared with microcapsules made solely of DNA. The hydrophobic core of the DNA-grafted PNIPAM micelles was designed to contain alkyne “click” groups, which were exploited to covalently couple azide-bearing low-fouling PEG to the DNA−PNIPAM microcapsules. The combination of hydrophobic and reactive “click” nanodomains, along with the degradability of DNA, offers a multifunctional and versatile DNA−polymer capsule system that is envisioned to find applications in the controlled delivery of therapeutics.
ISSN:1936-0851
1936-086X
DOI:10.1021/nn800705m